304 related articles for article (PubMed ID: 10914744)
1. Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor.
Laderoute KR; Alarcon RM; Brody MD; Calaoagan JM; Chen EY; Knapp AM; Yun Z; Denko NC; Giaccia AJ
Clin Cancer Res; 2000 Jul; 6(7):2941-50. PubMed ID: 10914744
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
[TBL] [Abstract][Full Text] [Related]
3. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
Pal S; Datta K; Mukhopadhyay D
Cancer Res; 2001 Sep; 61(18):6952-7. PubMed ID: 11559575
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
5. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
[TBL] [Abstract][Full Text] [Related]
6. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
[TBL] [Abstract][Full Text] [Related]
7. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression.
Mukhopadhyay D; Tsiokas L; Sukhatme VP
Cancer Res; 1995 Dec; 55(24):6161-5. PubMed ID: 8521408
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer.
Bouvet M; Ellis LM; Nishizaki M; Fujiwara T; Liu W; Bucana CD; Fang B; Lee JJ; Roth JA
Cancer Res; 1998 Jun; 58(11):2288-92. PubMed ID: 9622060
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen.
Catalano A; Romano M; Martinotti S; Procopio A
Oncogene; 2002 Apr; 21(18):2896-900. PubMed ID: 11973650
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression.
Mazure NM; Chen EY; Yeh P; Laderoute KR; Giaccia AJ
Cancer Res; 1996 Aug; 56(15):3436-40. PubMed ID: 8758908
[TBL] [Abstract][Full Text] [Related]
11. p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene.
Agani F; Kirsch DG; Friedman SL; Kastan MB; Semenza GL
Cancer Res; 1997 Oct; 57(20):4474-7. PubMed ID: 9377555
[TBL] [Abstract][Full Text] [Related]
12. Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis.
Viloria-Petit A; Crombet T; Jothy S; Hicklin D; Bohlen P; Schlaeppi JM; Rak J; Kerbel RS
Cancer Res; 2001 Jul; 61(13):5090-101. PubMed ID: 11431346
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.
Wei LH; Kuo ML; Chen CA; Chou CH; Lai KB; Lee CN; Hsieh CY
Oncogene; 2003 Mar; 22(10):1517-27. PubMed ID: 12629515
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis.
Rofstad EK; Danielsen T
Br J Cancer; 1999 Aug; 80(11):1697-707. PubMed ID: 10468285
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced changes in the expression of VEGF, HIF-1 alpha and cell cycle-related molecules in ovarian cancer cells.
Horiuchi A; Imai T; Shimizu M; Oka K; Wang C; Nikaido T; Konishi I
Anticancer Res; 2002; 22(5):2697-702. PubMed ID: 12529984
[TBL] [Abstract][Full Text] [Related]
16. [Vascular endothelial growth factor gene expression in nasopharyngeal carcinoma cell line induced by hypoxia in vitro].
Yang HF; Tang WP
Ai Zheng; 2003 Feb; 22(2):160-3. PubMed ID: 12600291
[TBL] [Abstract][Full Text] [Related]
17. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia.
Maity A; Pore N; Lee J; Solomon D; O'Rourke DM
Cancer Res; 2000 Oct; 60(20):5879-86. PubMed ID: 11059786
[TBL] [Abstract][Full Text] [Related]
19. Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor.
Gerber HP; Kowalski J; Sherman D; Eberhard DA; Ferrara N
Cancer Res; 2000 Nov; 60(22):6253-8. PubMed ID: 11103779
[TBL] [Abstract][Full Text] [Related]
20. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
